MIDAS VERDICT:

Technology needs to be tested before, during and after it comes to market. Spirent is a leader in the testing industry, the business is growing faster than ever and Updyke is confident that he can increase sales to $1billion in the next few years, even if economic conditions deteriorate. At £2.76, the shares are a buy.